# Boston Scientific (BSX) — Analyst Forecast

BSX · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bsx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 27 | 7 | 0 | 34 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $48.00 | $58.33 | $70.00 | 12 |

Last price $44.14 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Truist Securities | Maintained | Buy | $51.00 |
| Oct 7, 2026 | Barclays | Initiated Coverage | Equal-Weight | $48.00 |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | $48.00 |
| Sep 24, 2026 | Wells Fargo | Maintained | Equal-Weight | $48.00 |
| Sep 21, 2026 | Oppenheimer | Maintained | Outperform | $65.00 |
| Sep 17, 2026 | Citigroup | Downgraded | Buy → Neutral | $50.00 |
| Sep 9, 2026 | BTIG | Maintained | Buy | $56.00 |
| Aug 25, 2026 | TD Cowen | Maintained | Buy | $56.00 |
| Jul 31, 2026 | Argus Research | Downgraded | Buy → Hold | — |
| Jul 30, 2026 | Wells Fargo | Maintained | Equal-Weight | $50.00 |
| Jul 30, 2026 | Evercore ISI Group | Maintained | Outperform | $55.00 |
| Jul 30, 2026 | Truist Securities | Maintained | Buy | $57.00 |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | $66.00 |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | $56.00 |
| Jul 30, 2026 | RBC Capital | Maintained | Outperform | $70.00 |
| Jul 30, 2026 | Citigroup | Maintained | Buy | $61.00 |
| Jul 30, 2026 | UBS | Maintained | Buy | $67.00 |
| Jul 29, 2026 | BTIG | Maintained | Buy | $60.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Buy | $74.00 |
| Jul 27, 2026 | Oppenheimer | Maintained | Outperform | $85.00 |

## Frequently Asked Questions

### What is the price target for BSX stock?

The average 12-month analyst price target for Boston Scientific (BSX) is $58.33, with a high estimate of $70.00 and a low of $48.00, across 12 analysts.

### Is BSX a buy, sell, or hold?

Analysts covering Boston Scientific currently average a Buy rating: 27 buy, 7 hold and 0 sell, from 34 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BSX?

The average price target of $58.33 implies 32.16% upside from the last price of $44.14.

### What is the latest analyst rating on BSX?

On Oct 14, 2026, Truist Securities maintained Boston Scientific at Buy with a price target of $51.00.

## Similar Stocks

- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [ALGN](https://www.lighthorse.io/tickers/algn) — Align Technology, Inc. - Common Stock
- [ECL](https://www.lighthorse.io/tickers/ecl) — Ecolab Inc. Common Stock
- [DVA](https://www.lighthorse.io/tickers/dva) — DaVita Inc. Common Stock
- [MDT](https://www.lighthorse.io/tickers/mdt) — Medtronic plc. Ordinary Shares
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [HCA](https://www.lighthorse.io/tickers/hca) — HCA Healthcare, Inc. Common Stock
- [SYK](https://www.lighthorse.io/tickers/syk) — Stryker Corporation Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).